Text text text

Attendees will have the unique opportunity to tour ARUP Laboratories during the 2026 AMLI Annual Meeting.

August 4, 2026

ARUP Laboratories’ experts will share their insights on immunopathology at the upcoming 2026 Association of Medical Laboratory Immunologists (AMLI) Annual Meeting, covering topics such as emerging infectious diseases, recent advances in fungal diagnostics, and neuroimmunology biomarkers.

The conference will take place August 13–16, 2026, in Salt Lake City, and will offer attendees the opportunity to tour ARUP as well.

Refer to the information below for the full schedule of ARUP experts’ presentations and posters.

Representatives from ARUP will also be available at booth #3 in the exhibition hall, located in the Grand Ballroom, during coffee breaks.

Schedule

Presentations

Thursday, August 13, 2026

10:15 a.m. Meet the Exhibitors/Coffee Break

2:30 p.m. Meet the Exhibitors/Coffee Break

5:30 p.m. Tour of ARUP Laboratories

Friday, August 14, 2026

9:40 a.m. Emerging Infectious Diseases and Public Health Aspects 
Benjamin Bradley, MD, PhD, Head of Clinical Operations for Infectious Disease

10:15 a.m. Meet the Exhibitors/Coffee Break

10:45 a.m. Beyond Culture: Recent Advances and Future Needs in Fungal Diagnostics 
Kimberly Hanson, MD, MHS, Medical Director of Mycology

3:00 p.m. Meet the Exhibitors/Coffee Break

4:30 p.m. Neural Antibody Testing: Fabulous, Flummoxing, and Faulty 
Tammy Smith, MD, PhD, Clinical Consultant in Autoimmune Neurology

5:00 p.m. Poster Session/Meet the Exhibitors

Saturday, August 15, 2026

10:00 a.m. Meet the Exhibitors/Coffee Break

2:30 p.m. Bridging to Heart Transplant, While Igniting Antibodies: Cardiac Assist Devices and HLA Allosensitization 
Arevik Ghazaryan, PhD, Immunology Fellow, Future Leaders Award Honoree

5:00 p.m. Poster Session/Meet the Exhibitors

Sunday, August 16, 2026

10:00 a.m. Meet the Exhibitors/Coffee Break

11:00 a.m. Evaluation of Serum Tryptase Reference Intervals Using an Indirect Method 
Abdulrahman Saadalla, MB, BCh, Medical Director of the Immunology Core Lab and Coagulation

Posters

Board 2—Transplant Immunology: Bridging to Heart Transplant, While Igniting Antibodies: Cardiac Assist Devices and HLA Allosensitization

  • Arevik Ghazaryan, Denise Hurst, Ann Pole, Eszter Lazar-Molnar

Board 15—Other: Clinical Validation of Capillary Serum Tryptase To Enable Direct-to-Patient Testing

  • Christina Glenzel, Elizabeth Enrico, Nicholas Spiropulos, Amanda Openshaw, Guang Yang, Rentian Wu, Abdulrahman Saadalla

Board 21—Infectious Disease: Comparison of Two Chagas ELISA Assays Used in Tandem Testing Algorithm

  • Derek Stark, Patricia Slev

Board 22—Infectious Disease: Validation of an Antibody Index Assay for the Diagnosis of Lyme Neuroborreliosis

  • Derek Stark, Patricia Slev

Board 23—Transplant Immunology: Comparative Evaluation of Analytical Performance and Workflow Characteristics of Sequencing-Based Chimerism Assays for Post-Transplant Monitoring Across Diverse Clinical Scenarios

  • Dharmendra Jain, Andre Cruz-Delgadillo, Julio Delgado, Eszter Lazar-Molnar

Board 24—Autoimmune Disease: Performance Evaluation of MosaiQ AiPlex® Vasculitis (VAS) Assay for the Detection of MPO, PR3, and GBM Antibodies

  • Dipanwita Banerjee, Melanie Sorensen, Michael Faust, Olivia Lorton, Lisa Peterson, Jose Santiago, Kathy Phan

Board 29—Other: Conversion of Lymphocyte Subsets Assay From 3 to 1 Tube Format

  • Eugene Ravkov, Jenifer De Juan, Swapna Gudipaty, Garrin Abbott, Leo Lin

Board 35—Infectious Disease: Analytical Validation of the Tasso+ Device for Remote HCV Antibody and RNA Testing in Capillary Blood To Improve Diagnosis in Remote and Austere Conditions

  • Janani Sankar, Elizabeth Enrico, Christina Glenzel, Benjamin Bradley

Board 48—Autoimmune Disease: Method Comparison Between the Investigational Use Only MosaiQ AiPlex Celiac Disease Microarray Immunoplex Assay to the Aptiva

  • Michael Faust, Dipanwita Banerjee, Olivia Lorton, Kathy Phan, Jose Santiago, Lisa Peterson, Abdulrahman Saadalla

Board 64—Other: Validation of a Basophil Activation Test for the Assessment of Peanut Allergy in a Clinical Laboratory Setting

  • Thomas Martins, Michael Faust, Mili Shum, Abdulrahman Saadalla

Board 65—Autoimmune Disease: The Clinical Utility of Elevated DGP-IgA Antibodies in the Diagnosis of Celiac Disease

  • Tracie Profaizer, Abdulrahman Saadalla

 

Alice To, alice.to@aruplab.com